Latest Product News
Waters Sets New Standard in High Resolution Mass Spectrometry
Waters Corporation has introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced DESI and new MALDI imaging sources.
Taking the Strain Out of Microplate Sealing
Porvair Sciences has announced its next-generation AutoCapper electronic sealer - a versatile device designed to take the strain out of applying friction sealing caps to a wide range of microplates.
Foresight Diagnostics Completes Series A Financing To Accelerate Minimal Residual Disease Technology
Foresight Diagnostics has announced the close of its $12.5M Series A financing to commercialize the minimal residual disease (MRD) detection assay.
Indica Labs Partners With Ibex To Deliver AI-Powered Clinical Workflows
Indica Labs and Ibex Medical Analytics have announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform.
GammaDelta Therapeutics Receives FDA Clearance For Novel Cell Cancer Therapy
GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,
Macrogen Europe Expands Sequencing Capacity
Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.
Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research
Flow Eighteen38 and FairJourney Biologics S.A. have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools.
Cmed Group Joins AIXIAL, the CRO of ALTEN Group
AIXIAL, the CRO of ALTEN Group, announces the acquisition of UK headquartered CMED Group by ALTEN EUROPE.
H.E.L Group Appoints Sales Director for Asia-Pacific
H.E.L Group has announced the appointment of Oh Chee Keat (Brice Oh) as Regional Sales Director for Asia-Pacific.
Mogrify Completes Series A Financing Totaling $33 Million USD
Mogrify Limited has announced the second closing of its Series A financing of $17 million USD, bringing the total raised to $33 million USD in this round. The funding will support the advancement of Mogrify’s immuno-oncology and ophthalmology programs, as well as continued platform development and the exploration of cell reprogramming for novel therapeutic applications.